BTIG Downgrades Taysha Gene Therapies to Neutral

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

byBenzinga Newsdesk

February 2, 2023

1 minute read

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

Here’s Why Piper Sandler Downgraded AMD, Slashed Price Target By 7%

By Anusuya Lahiri

Today, 9:51 PM

Piper Sandler analyst Harsh Kumar downgraded Advanced Micro Devices Inc (NASDAQ:AMD) to Neutral from Overweight with a price target of $130, down from…

AMD

Is Costco Raising The Price Of Its Famous Hot Dog Due To Inflation?

By Chris Katje

Today, 9:51 PM

Being able to get a hot dog and soda for the low price of $1.50 has become a staple for Costco Wholesale Corporation (NASDAQ: COST) stores. Is the membership warehouse club raising the price of the combo finally?

COST

Piper Sandler Maintains Overweight on Valero Energy, Lowers Price Target to $148

By Benzinga Newsdesk

Today, 9:51 PM

Piper Sandler analyst Ryan Todd maintains Valero Energy (NYSE:VLO) with a Overweight and lowers the price target from $150 to $148.

VLO

Investor Optimism Decreases Further After U.S. Stocks Record Weekly Losses

By Lisa Levin

Today, 9:51 PM

The CNN Money Fear and Greed index remained in the "neutral" zone on Monday amid a sharp decline in the US stocks on Friday. U.S. Treasury yields rose, as the benchmark 10-year note surged to around 3%, after Germany recorded a record-high surge in monthly producer prices.

BBBY

BTIG Downgrades Taysha Gene Therapies to Neutral

Related Posts

Here’s Why Piper Sandler Downgraded AMD, Slashed Price Target By 7%

Is Costco Raising The Price Of Its Famous Hot Dog Due To Inflation?

Piper Sandler Maintains Overweight on Valero Energy, Lowers Price Target to $148

Investor Optimism Decreases Further After U.S. Stocks Record Weekly Losses